[PDF] Top 20 Derecho al trabajo de las personas con discapacidad
Has 10000 "Derecho al trabajo de las personas con discapacidad" found on our website. Below are the top 20 most common "Derecho al trabajo de las personas con discapacidad".
New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents
... the treatment of ...the role of splenectomy now in ITP? How does use the of TPO mimetics change the course of ITP? In addition, it is very likely that the cost of TPO mimetics over extended periods of time ... See full document
14
Long-term management of chronic immune thrombocytopenic purpura in adults
... by stimulating platelet ...thrombopoiesis-stimulating agents (eg, thrombopoietin (TPO) receptor agonists), including recombinant TPOs (which are no longer available), peptide TPO ... See full document
14
Eltrombopag Managed Severe Immune Thrombocytopenic Purpura in Pregnancy: A Case Report, Latifa Hospital, DHA, Dubai, UAE
... and immune destruction of ...of treatment. Although Ri- tuximab and Thrombopoietin receptor agonists are useful second line agents in non-pregnant adults, the data about their ... See full document
109
An unusual occurrence of Kleine Levin syndrome in a man with refractory immune thrombocytopenic purpura: a case report
... having chronic refractory ITP. There is a predicament whether treatment should be con- tinued and is of acceptable benefit in this group of patients as current third-line drugs are mostly immunosuppressive ... See full document
11
Inherited thrombotic thrombocytopenic purpura mimicking immune thrombocytopenic purpura during pregnancy: a case report
... Other systemic pregnancy-associated syndromes such as HELLP may lead to a misdiagnosis of inherited TTP. HELLP syndrome (hemolytic anemia, elevated liver enzymes and low platelet count) occurs with pregnancy induced by ... See full document
8
Common variable immunodeficiency unmasked by treatment of immune thrombocytopenic purpura with Rituximab
... After a vacation in Mallorca spent sailing in December 2010 the patient returned home with an upper respiratory tract infection as well as diarrhoea and vomiting. The pa- tient developed high fevers and confusion and was ... See full document
97
Chronic Immune Thrombocytopenic Purpura in a Young Female with Rheumatoid Arthritis (Unusual Course)
... This treatment was based on a theory originally conceived and presented by Dr Roger Wyburn-Mason who suggested that all rheumatic diseases are caused by amoeba and thus can be neutralized by using ... See full document
83
Review Of Literature With Current Treatment Guidelines For Idiopathic Thrombocytopenic (Itp)
... and treatment-related ...a role of combination chemotherapy to treat chronic refractory ITP to achieve greater efficacy and fewer adverse ...with chronic refractory ITP, lasting a median of 24 ... See full document
24
Acute Immune Thrombocytopenic Purpura in Infants
... to treatment, 66 patients received IVIG with or without corticosteroids and 52 patients showed complete response to the initial ...had chronic ITP that 10 patients ...the chronic phase (Pvalue: ... See full document
6
Tuberculosis presenting as immune thrombocytopenic purpura
... the adult ITP not only by basing on standard criteria [12], but with response to steroids and IVIg therapy since thrombocytopenia did not recur after withdrawal of prednisone and IVIg ... See full document
16
Recurrent Immune Thrombocytopenia After Influenza Vaccination: A Case Report
... Almost all patients diagnosed with ITP have signs of cutaneous bleeding (petechiae, purpura, and ecchymoses). Mucosal bleeding can occur in as many as 40% of children, usually involving the nasal passages and ... See full document
7
Roles of CD5 , CD19 , CD41a , CD55 and CD59 in Chronic Immune Thrombocytopenic Purpura (ITP)
... The chronic ITP patients were evaluated according to their requirements of ...discontinued treatment for various ...methylprednisolone treatment were divided into two subgroups according to their ... See full document
21
Platelet antibodies of the IgM class in immune thrombocytopenic purpura
... with immune thrombocytopenic purpura (ITP) are not completely determined by the level of IgG present on the platelet ...a role in platelet destruction in some of these ... See full document
86
<p>Post-Transfusion Purpura: Current Perspectives</p>
... post-transfusion purpura was coined in 1961, over 250 cases have been reported in the literature, 64 yet PTP is still considered a relatively rare hazard of blood ...key role in autologous platelet ... See full document
6
Clinical Variables among Adult Patients with Chronic Idiopathic Thrombocytopenic Purpura in West Iran
... Therefore, Hb and WBC count among our chronic ITP patients did not seem to be low and might be even somehow higher than the normal range. Also, we observed that Hb count was higher in our patients with H pylori ... See full document
58
Value of Pre and Post Treatment Platelet Indices in Patients with Immune Thrombocytopenic Purpura
... of treatment, compared to its values at the time of ...line treatment was consistent with the change of PLT count as proved by Liu and colleagues, 2016 and Korkmaz et al ...the treatment [36] [24]. ... See full document
217
New advances in the treatment of generalized lipodystrophy: role of metreleptin
... or adult subjects, though careful adjustment of dosing regime is required in adolescent subjects, as they age and increase in body size and ...start treatment at the lower end of the dosing ... See full document
5
Report of a ‘Consensus’ on the Lines of Treatment for Primary Immune Thrombocytopenia in Adults, Promoted by the Italian Gruppo di Studio delle Piastrine
... The publication of a paper on ‘terms and definitions of immune thrombocytopenia’ (ITP) by the International Working Group on ITP in 2009 (2009 IWG) [1] represented a fundamental step in the management of ITP. ... See full document
146
Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia
... of treatment, while the ROMI trial allowed dose reduction or discontinuation of ITP medica- tions during the first 12 weeks of treatment, which may have impacted platelet ... See full document
6
Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle
... required as number of megacaryocytes can actually vary substantially and do not necessarily correlate with extent of thrombocytopenia. However, we recommend performing a bone marrow biopsy for treatment of ... See full document
82
Related subjects